Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

NCT07618936 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT07618936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07618936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
Lead sponsor
Tianjin Medical University
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2026
Completion date
June 1, 2031
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pd-l1 gene amplification, pd-l1 gene mutation, pd-l1-related disease, positron emission tomography